新型靶向间皮素的嵌合抗原受体修饰 UNKT 细胞高效抑制肿瘤进展

间皮素作为癌症免疫治疗的生物标志物和治疗靶点

Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer.

癌症仍是一个关键的全球健康问题，原因在于发现晚、耐药和高死亡率。

PARP 抑制剂联合安罗替尼作为卵巢癌装甲 CAR-T 细胞的桥接治疗可增强浸润与抗肿瘤疗效

PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.

CAR-T 细胞治疗胰腺癌的进展、挑战与创新策略

Advances, challenges, and innovative strategies of CAR-T cell therapy in pancreatic cancer.

模块化 γδ TCR-T 平台：结合 KRAS pMHC 靶向与可重复给药 mRNA 衔接器重定向

A modular γδ TCR-T platform combining KRAS pMHC targeting with re-dosable mRNA engager redirection.

靶向 MUC16 的膀胱内间皮素 CAR-T 细胞在临床前模型中有效控制膀胱癌

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

寻找 AML 中安全有效的 CAR-T 靶点

The search for safe and effective CAR-T targets in AML.